Office of the Director, National Institutes of Health; Notice of Meeting, 48222 [E8-18875]

Download as PDF 48222 Federal Register / Vol. 73, No. 160 / Monday, August 18, 2008 / Notices 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. sroberts on PROD1PC70 with NOTICES Name of Committee: National Institute of Mental Health Special Emphasis Panel; Genomic Parsing of Bipolar Disorder and Schizophrenia: Independent R01’s. Date: August 12, 2008. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Peter J. Sheridan, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MSC 9606, Bethesda, MD 20892, 301–443–1513, psherida@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Genomic Parsing of Bipolar Disorder and Schizophrenia: Collaborative R01’s. Date: August 14, 2008. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Peter J. Sheridan, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MSC 9606, Bethesda, MD 20892, 301–443–1513, psherida@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: August 8, 2008. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–18985 Filed 8–15–08; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 16:50 Aug 15, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Recombinant DNA Advisory Committee. Date: September 9–10, 2008. Time: September 9, 2008, 1 p.m. to 5:30 p.m. Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols as well as related data management activities. Please check the meeting agenda at https:// www4.od.nih.gov/oba/RAC/meeting.htm for more information. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Rooms E1 & E2, Bethesda, MD 20892. Time: September 10, 2008, 8:15 a.m. to 4 p.m. Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols. There will be a discussion of the review process for single subject protocols and a discussion of biosafety containment and practices for recombinant work with non-contemporary strains of influenza and the highly pathogenic avian influenza strain H5N1. https://www.4od.nih.gov/oba/RAC/ meeting.htm. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Rooms E1 & E2, Bethesda, MD 20892. Contact Person: Jacqueline Corrigan-Curay, JD, MD, Executive Secretary, Recombinant DNA Advisory Committee, Office of Biotechnology Activites, OSP, OD, Rockledge 1, Room 750, Bethesda, MD 20892, 301–435– 2151, corrigaja@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Information is also available on the Institute’s/Center’s home page: https:// www4.od.nih.gov/oba/, where an agenda and any additional information for the meeting will be posted when available. OMB’s ‘‘Mandatory Information Requirements for Federal Assistance Program Announcements’’ (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to attempt to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions to the information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: August 8, 2008. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–18875 Filed 8–15–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: The Coordinating Center to Support State Incentive Grants to Build E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 73, Number 160 (Monday, August 18, 2008)]
[Notices]
[Page 48222]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18875]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: September 9-10, 2008.
    Time: September 9, 2008, 1 p.m. to 5:30 p.m.
    Agenda: The Recombinant DNA Advisory Committee will review and 
discuss selected human gene transfer protocols as well as related 
data management activities. Please check the meeting agenda at 
https://www4.od.nih.gov/oba/RAC/meeting.htm for more information.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Rooms E1 & E2, Bethesda, MD 20892.
    Time: September 10, 2008, 8:15 a.m. to 4 p.m.
    Agenda: The Recombinant DNA Advisory Committee will review and 
discuss selected human gene transfer protocols. There will be a 
discussion of the review process for single subject protocols and a 
discussion of biosafety containment and practices for recombinant 
work with non-contemporary strains of influenza and the highly 
pathogenic avian influenza strain H5N1. https://www.4od.nih.gov/oba/
RAC/meeting.htm.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Rooms E1 & E2, Bethesda, MD 20892.
    Contact Person: Jacqueline Corrigan-Curay, JD, MD, Executive 
Secretary, Recombinant DNA Advisory Committee, Office of 
Biotechnology Activites, OSP, OD, Rockledge 1, Room 750, Bethesda, 
MD 20892, 301-435-2151, corrigaja@od.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: https://www4.od.nih.gov/oba/, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: August 8, 2008.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-18875 Filed 8-15-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.